Showing results (111-120 of 122) with videos related to
Sort By:
Pageof 13
Thrombosis and Haemostasis|November 8, 2013
Nicotinamide phosphoribosyltransferase inhibition reduces intraplaque CXCL1 production and associated neutrophil infiltration in atherosclerotic miceAlessio Nencioni, Rafaela F da Silva, Rodrigo A Fraga-Silva, et al.The Lancet. Oncology|September 20, 2021
Extended therapy with letrozole as adjuvant treatment of postmenopausal patients with early-stage breast cancer: a multicentre, open-label, randomised, phase 3 trialLucia Del Mastro, Mauro Mansutti, Giancarlo Bisagni, et al.The Journal of Pathology|April 9, 2015
Uncovering the genomic heterogeneity of multifocal breast cancerChristine Desmedt, Debora Fumagalli, Elisabetta Pietri, et al.The Lancet. Oncology|August 13, 2019
Neoadjuvant letrozole plus taselisib versus letrozole plus placebo in postmenopausal women with oestrogen receptor-positive, HER2-negative, early-stage breast cancer (LORELEI): a multicentre, randomised, double-blind, placebo-controlled, phase 2 trialCristina Saura, Dominik Hlauschek, Mafalda Oliveira, et al.Heliyon|November 6, 2023
Diagnosis of lung cancer following emergency admission: Examining care pathways, clinical outcomes, and advanced NSCLC treatment in an Italian cancer CenterGiacomo Vallome, Iacopo Cafaro, Annarita Bottini, et al.Journal of the National Comprehensive Cancer Network : JNCCN|January 12, 2023
Impact of Anti-HER2 Therapy Alone and With Weekly Paclitaxel on the Ovarian Reserve of Young Women With HER2-Positive Breast CancerMatteo Lambertini, Marcello Ceppi, Richard A Anderson, et al.BMJ Open|January 7, 2021
Prospective validation study of prognostic biomarkers to predict adverse outcomes in patients with COVID-19: a study protocolBenjamin Tang, Maryam Shojaei, Ya Wang, et al.Cancers|April 25, 2020
Insights into Genetic Susceptibility to Melanoma by Gene Panel Testing: Potential Pathogenic Variants in ACD, ATM, BAP1, and POT1Lorenza Pastorino, Virginia Andreotti, Bruna Dalmasso, et al.European Journal of Cancer (Oxford, England : 1990)|February 16, 2022
Serum thymidine kinase activity in patients with hormone receptor-positive and HER2-negative metastatic breast cancer treated with palbociclib and fulvestrantLuca Malorni, Svitlana Tyekucheva, Florentine S Hilbers, et al.Nature|July 17, 2020
Fasting-mimicking diet and hormone therapy induce breast cancer regressionIrene Caffa, Vanessa Spagnolo, Claudio Vernieri, et al.Pageof 13